More severe CF transmembrane conductance regulator (CFTR) mutations are associated with poorer clinical outcomes [5]; however, identification of exogenous factors that contribute to the inflammatory process and susceptibility to infection may provide an opportunity for intervention. Here, CFTR is linked to infection.